Direkt zum Inhalt
Merck

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Stem cells and development (2014-07-24)
Alexandre Janel, Frédérique Dubois-Galopin, Céline Bourgne, Juliette Berger, Karin Tarte, Nathalie Boiret-Dupré, Stéphane Boisgard, Pierre Verrelle, Pierre Déchelotte, Olivier Tournilhac, Marc G Berger
ZUSAMMENFASSUNG

The systematic localization of chronic lymphocytic leukemia (CLL) B-cells in the bone marrow (BM), together with the ex vivo protective effect of stromal cells on their spontaneous apoptosis, both indicate a specific role of the BM microenvironment. In vivo, the impact of CLL cells on mesenchymal stromal cells (MSCs) remains a source of debate. Here, we quantified and expanded colony forming unit-fibroblasts (CFU-Fs) from CLL-BM under standard conditions, analyzed the expression of selected genes, and studied secretion profiles. We observed failing of CLL-BM cultures in standard conditions (45.5% vs. <0.1%), and even after adding basic fibroblast growth factor (bFGF), there were fewer CFU-F than from normal BM (1.3 vs. 40/10(6) cells respectively; P<0.01). Furthermore, their polygonal aspect and low proliferative capacity, together with the expression of 384 selected genes and a secreted set of molecules related to senescence-associated secretory phenotype indicated a state of senescence, further confirmed by the higher proportion of senescence-associated β-galactosidase (SA-βGAL)-positive cells and p16INK4a overexpression. In our hands, hypoxic conditions (5% O2) did not rescue CFU-Fs. Given the role of MSC in BM tissue organization, we studied hematons that are generally considered to be elementary BM units. These structures were rare or had even disappeared completely. When hematons were present, we systematically observed nodular B-CLL cell invasion only. These data confirm that the B-CLL clone has a marked impact on MSC and disrupts BM organization in vivo, raising new questions about in vivo pathophysiology.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ammoniumhydroxid -Lösung, ACS reagent, 28.0-30.0% NH3 basis
Sigma-Aldrich
Ammoniumhydroxid -Lösung, 28% NH3 in H2O, ≥99.99% trace metals basis
Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-Ascorbinsäure, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-Ascorbinsäure, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L-Ascorbinsäure, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-Ascorbinsäure, 99%
Sigma-Aldrich
L-Ascorbinsäure, reagent grade, crystalline
Supelco
Ascorbinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutamin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
Sigma-Aldrich
Natriumselenit, 99%
USP
Ascorbinsäure, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Natriumselenit, BioReagent, suitable for cell culture, ≥98%
SAFC
L-Glutamin
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Indomethacin, 98.0-102.0%, meets EP testing specifications
Sigma-Aldrich
Natriumselenit, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hämatoxylin
Sigma-Aldrich
L-Ascorbinsäure, ACS reagent, ≥99%
Supelco
L-Ascorbinsäure, analytical standard
Sigma-Aldrich
L-Ascorbinsäure, meets USP testing specifications
Sigma-Aldrich
Ammoniumhydroxid -Lösung, BioUltra, ~1 M NH3 in H2O (T)
Sigma-Aldrich
L-Ascorbinsäure, reagent grade
Sigma-Aldrich
Hämatoxylin, certified by the BSC
Supelco
Dexamethason, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dexamethason, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-Glutamin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-Ascorbinsäure, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)